Terms: = Lung cancer AND FBXO11, MGC44383, 80204, ENSG00000138081, Q86XK2, VIT1, UG063H01, PRMT9, FLJ12673, FBX11
6 results:
1. A hsa_circ_001726 axis regulated by E2F6 contributes to metastasis of hepatocellular carcinoma.
Ai J; Zhang W; Deng W; Yan L; Zhang L; Huang Z; Wu Z; Ai J; Jiang H
BMC Cancer; 2024 Jan; 24(1):14. PubMed ID: 38166853
[TBL] [Abstract] [Full Text] [Related]
2. Identification of THSD7B and prmt9 mutations as risk factors for familial lung adenocarcinoma: A case report.
Zhang Q; Zhao Y; Song Z; Zhang Q; Tian C; Li R; Zheng J; Yan L; Gu M; Jia X; Li M
Medicine (Baltimore); 2023 Feb; 102(6):e32872. PubMed ID: 36820582
[TBL] [Abstract] [Full Text] [Related]
3. miR-324-5p upregulation potentiates resistance to cisplatin by targeting fbxo11 signalling in non-small cell lung cancer cells.
Ba Z; Zhou Y; Yang Z; Xu J; Zhang X
J Biochem; 2019 Dec; 166(6):517-527. PubMed ID: 31778188
[TBL] [Abstract] [Full Text] [Related]
4. prmt9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling.
Jiang H; Zhou Z; Jin S; Xu K; Zhang H; Xu J; Sun Q; Wang J; Xu J
Cancer Sci; 2018 May; 109(5):1414-1427. PubMed ID: 29603830
[TBL] [Abstract] [Full Text] [Related]
5. PKD1 phosphorylation-dependent degradation of SNAIL by SCF-fbxo11 regulates epithelial-mesenchymal transition and metastasis.
Zheng H; Shen M; Zha YL; Li W; Wei Y; Blanco MA; Ren G; Zhou T; Storz P; Wang HY; Kang Y
Cancer Cell; 2014 Sep; 26(3):358-373. PubMed ID: 25203322
[TBL] [Abstract] [Full Text] [Related]
6. [Screening and identification of human lung cancer-related antigens].
Liu HY; Peng LP; Ran YL; Zhang LZ; Zhang DC; Zhu YK; Yang ZH
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):171-5. PubMed ID: 12006991
[TBL] [Abstract] [Full Text] [Related]
